nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.00479	0.248	CbGbCtD
Indapamide—CYP3A4—Triamcinolone—ankylosing spondylitis	0.00363	0.188	CbGbCtD
Indapamide—CYP3A4—Betamethasone—ankylosing spondylitis	0.00311	0.161	CbGbCtD
Indapamide—CYP3A4—Prednisolone—ankylosing spondylitis	0.00307	0.159	CbGbCtD
Indapamide—CYP3A4—Prednisone—ankylosing spondylitis	0.0029	0.15	CbGbCtD
Indapamide—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00181	0.0937	CbGbCtD
Indapamide—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.00131	0.00133	CcSEcCtD
Indapamide—Malaise—Betamethasone—ankylosing spondylitis	0.0013	0.00133	CcSEcCtD
Indapamide—Malaise—Dexamethasone—ankylosing spondylitis	0.0013	0.00133	CcSEcCtD
Indapamide—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.0013	0.00132	CcSEcCtD
Indapamide—Oedema—Triamcinolone—ankylosing spondylitis	0.0013	0.00132	CcSEcCtD
Indapamide—Vertigo—Betamethasone—ankylosing spondylitis	0.0013	0.00132	CcSEcCtD
Indapamide—Vertigo—Dexamethasone—ankylosing spondylitis	0.0013	0.00132	CcSEcCtD
Indapamide—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.0013	0.00132	CcSEcCtD
Indapamide—Syncope—Betamethasone—ankylosing spondylitis	0.0013	0.00132	CcSEcCtD
Indapamide—Syncope—Dexamethasone—ankylosing spondylitis	0.0013	0.00132	CcSEcCtD
Indapamide—Arrhythmia—Prednisone—ankylosing spondylitis	0.00129	0.00132	CcSEcCtD
Indapamide—Infection—Triamcinolone—ankylosing spondylitis	0.00129	0.00132	CcSEcCtD
Indapamide—Sweating—Methotrexate—ankylosing spondylitis	0.00129	0.00132	CcSEcCtD
Indapamide—Infection—Methylprednisolone—ankylosing spondylitis	0.00129	0.00131	CcSEcCtD
Indapamide—Shock—Triamcinolone—ankylosing spondylitis	0.00128	0.0013	CcSEcCtD
Indapamide—Insomnia—Prednisolone—ankylosing spondylitis	0.00128	0.0013	CcSEcCtD
Indapamide—Shock—Methylprednisolone—ankylosing spondylitis	0.00128	0.0013	CcSEcCtD
Indapamide—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00127	0.0013	CcSEcCtD
Indapamide—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00127	0.0013	CcSEcCtD
Indapamide—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00127	0.00129	CcSEcCtD
Indapamide—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00127	0.00129	CcSEcCtD
Indapamide—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00127	0.00129	CcSEcCtD
Indapamide—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00127	0.00129	CcSEcCtD
Indapamide—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00127	0.00129	CcSEcCtD
Indapamide—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00126	0.00128	CcSEcCtD
Indapamide—Erythema—Prednisone—ankylosing spondylitis	0.00126	0.00128	CcSEcCtD
Indapamide—Malnutrition—Prednisone—ankylosing spondylitis	0.00126	0.00128	CcSEcCtD
Indapamide—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00126	0.00128	CcSEcCtD
Indapamide—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00126	0.00128	CcSEcCtD
Indapamide—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00125	0.00128	CcSEcCtD
Indapamide—Myalgia—Dexamethasone—ankylosing spondylitis	0.00123	0.00125	CcSEcCtD
Indapamide—Myalgia—Betamethasone—ankylosing spondylitis	0.00123	0.00125	CcSEcCtD
Indapamide—Anxiety—Dexamethasone—ankylosing spondylitis	0.00123	0.00125	CcSEcCtD
Indapamide—Anxiety—Betamethasone—ankylosing spondylitis	0.00123	0.00125	CcSEcCtD
Indapamide—Discomfort—Dexamethasone—ankylosing spondylitis	0.00121	0.00124	CcSEcCtD
Indapamide—Discomfort—Betamethasone—ankylosing spondylitis	0.00121	0.00124	CcSEcCtD
Indapamide—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00121	0.00124	CcSEcCtD
Indapamide—Pain—Prednisolone—ankylosing spondylitis	0.00121	0.00123	CcSEcCtD
Indapamide—Hepatitis—Methotrexate—ankylosing spondylitis	0.00121	0.00123	CcSEcCtD
Indapamide—Pharyngitis—Methotrexate—ankylosing spondylitis	0.0012	0.00122	CcSEcCtD
Indapamide—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00119	0.00122	CcSEcCtD
Indapamide—Vision blurred—Prednisone—ankylosing spondylitis	0.00119	0.00121	CcSEcCtD
Indapamide—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00118	0.00121	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00118	0.00121	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00118	0.0012	CcSEcCtD
Indapamide—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00118	0.0012	CcSEcCtD
Indapamide—Oedema—Betamethasone—ankylosing spondylitis	0.00118	0.0012	CcSEcCtD
Indapamide—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00118	0.0012	CcSEcCtD
Indapamide—Oedema—Dexamethasone—ankylosing spondylitis	0.00118	0.0012	CcSEcCtD
Indapamide—Insomnia—Triamcinolone—ankylosing spondylitis	0.00118	0.0012	CcSEcCtD
Indapamide—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00117	0.0012	CcSEcCtD
Indapamide—Infection—Dexamethasone—ankylosing spondylitis	0.00117	0.00119	CcSEcCtD
Indapamide—Infection—Betamethasone—ankylosing spondylitis	0.00117	0.00119	CcSEcCtD
Indapamide—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00117	0.00119	CcSEcCtD
Indapamide—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00117	0.00119	CcSEcCtD
Indapamide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00116	0.00119	CcSEcCtD
Indapamide—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00116	0.00119	CcSEcCtD
Indapamide—Visual impairment—Methotrexate—ankylosing spondylitis	0.00116	0.00119	CcSEcCtD
Indapamide—Anaemia—Prednisone—ankylosing spondylitis	0.00116	0.00119	CcSEcCtD
Indapamide—Shock—Betamethasone—ankylosing spondylitis	0.00116	0.00118	CcSEcCtD
Indapamide—Shock—Dexamethasone—ankylosing spondylitis	0.00116	0.00118	CcSEcCtD
Indapamide—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00116	0.00118	CcSEcCtD
Indapamide—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00116	0.00118	CcSEcCtD
Indapamide—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00116	0.00118	CcSEcCtD
Indapamide—Agitation—Prednisone—ankylosing spondylitis	0.00116	0.00118	CcSEcCtD
Indapamide—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00115	0.00118	CcSEcCtD
Indapamide—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00115	0.00118	CcSEcCtD
Indapamide—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00115	0.00117	CcSEcCtD
Indapamide—Tachycardia—Betamethasone—ankylosing spondylitis	0.00115	0.00117	CcSEcCtD
Indapamide—Angioedema—Prednisone—ankylosing spondylitis	0.00115	0.00117	CcSEcCtD
Indapamide—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00114	0.00117	CcSEcCtD
Indapamide—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00114	0.00116	CcSEcCtD
Indapamide—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00114	0.00116	CcSEcCtD
Indapamide—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00114	0.00116	CcSEcCtD
Indapamide—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00114	0.00116	CcSEcCtD
Indapamide—Malaise—Prednisone—ankylosing spondylitis	0.00113	0.00116	CcSEcCtD
Indapamide—Vertigo—Prednisone—ankylosing spondylitis	0.00113	0.00115	CcSEcCtD
Indapamide—Syncope—Prednisone—ankylosing spondylitis	0.00113	0.00115	CcSEcCtD
Indapamide—Tinnitus—Methotrexate—ankylosing spondylitis	0.00113	0.00115	CcSEcCtD
Indapamide—Anorexia—Betamethasone—ankylosing spondylitis	0.00112	0.00115	CcSEcCtD
Indapamide—Anorexia—Dexamethasone—ankylosing spondylitis	0.00112	0.00115	CcSEcCtD
Indapamide—Urticaria—Prednisolone—ankylosing spondylitis	0.00112	0.00114	CcSEcCtD
Indapamide—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00112	0.00114	CcSEcCtD
Indapamide—Fatigue—Triamcinolone—ankylosing spondylitis	0.00112	0.00114	CcSEcCtD
Indapamide—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00112	0.00114	CcSEcCtD
Indapamide—Pain—Triamcinolone—ankylosing spondylitis	0.00111	0.00113	CcSEcCtD
Indapamide—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00111	0.00113	CcSEcCtD
Indapamide—Hypotension—Betamethasone—ankylosing spondylitis	0.0011	0.00112	CcSEcCtD
Indapamide—Hypotension—Dexamethasone—ankylosing spondylitis	0.0011	0.00112	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00107	0.0011	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00107	0.0011	CcSEcCtD
Indapamide—Arthralgia—Prednisone—ankylosing spondylitis	0.00107	0.00109	CcSEcCtD
Indapamide—Myalgia—Prednisone—ankylosing spondylitis	0.00107	0.00109	CcSEcCtD
Indapamide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00107	0.00109	CcSEcCtD
Indapamide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00107	0.00109	CcSEcCtD
Indapamide—Anxiety—Prednisone—ankylosing spondylitis	0.00107	0.00109	CcSEcCtD
Indapamide—Insomnia—Dexamethasone—ankylosing spondylitis	0.00107	0.00109	CcSEcCtD
Indapamide—Insomnia—Betamethasone—ankylosing spondylitis	0.00107	0.00109	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00106	0.00108	CcSEcCtD
Indapamide—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00106	0.00108	CcSEcCtD
Indapamide—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00106	0.00108	CcSEcCtD
Indapamide—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00106	0.00108	CcSEcCtD
Indapamide—Discomfort—Prednisone—ankylosing spondylitis	0.00106	0.00108	CcSEcCtD
Indapamide—Malnutrition—Methotrexate—ankylosing spondylitis	0.00105	0.00107	CcSEcCtD
Indapamide—Erythema—Methotrexate—ankylosing spondylitis	0.00105	0.00107	CcSEcCtD
Indapamide—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00104	0.00106	CcSEcCtD
Indapamide—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00104	0.00106	CcSEcCtD
Indapamide—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00104	0.00106	CcSEcCtD
Indapamide—Urticaria—Triamcinolone—ankylosing spondylitis	0.00103	0.00105	CcSEcCtD
Indapamide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00103	0.00105	CcSEcCtD
Indapamide—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00103	0.00105	CcSEcCtD
Indapamide—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00103	0.00105	CcSEcCtD
Indapamide—Oedema—Prednisone—ankylosing spondylitis	0.00103	0.00105	CcSEcCtD
Indapamide—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00103	0.00105	CcSEcCtD
Indapamide—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00102	0.00104	CcSEcCtD
Indapamide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00102	0.00104	CcSEcCtD
Indapamide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00102	0.00104	CcSEcCtD
Indapamide—Infection—Prednisone—ankylosing spondylitis	0.00102	0.00104	CcSEcCtD
Indapamide—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00102	0.00104	CcSEcCtD
Indapamide—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00102	0.00104	CcSEcCtD
Indapamide—Back pain—Methotrexate—ankylosing spondylitis	0.00102	0.00104	CcSEcCtD
Indapamide—Fatigue—Dexamethasone—ankylosing spondylitis	0.00102	0.00104	CcSEcCtD
Indapamide—Fatigue—Betamethasone—ankylosing spondylitis	0.00102	0.00104	CcSEcCtD
Indapamide—Shock—Prednisone—ankylosing spondylitis	0.00101	0.00103	CcSEcCtD
Indapamide—Pain—Dexamethasone—ankylosing spondylitis	0.00101	0.00103	CcSEcCtD
Indapamide—Pain—Betamethasone—ankylosing spondylitis	0.00101	0.00103	CcSEcCtD
Indapamide—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00101	0.00103	CcSEcCtD
Indapamide—Tachycardia—Prednisone—ankylosing spondylitis	0.001	0.00102	CcSEcCtD
Indapamide—Skin disorder—Prednisone—ankylosing spondylitis	0.000997	0.00102	CcSEcCtD
Indapamide—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000992	0.00101	CcSEcCtD
Indapamide—Vision blurred—Methotrexate—ankylosing spondylitis	0.000991	0.00101	CcSEcCtD
Indapamide—Anorexia—Prednisone—ankylosing spondylitis	0.000979	0.000998	CcSEcCtD
Indapamide—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000975	0.000995	CcSEcCtD
Indapamide—Anaemia—Methotrexate—ankylosing spondylitis	0.000972	0.000991	CcSEcCtD
Indapamide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000971	0.000991	CcSEcCtD
Indapamide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000971	0.000991	CcSEcCtD
Indapamide—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000964	0.000983	CcSEcCtD
Indapamide—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000964	0.000983	CcSEcCtD
Indapamide—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000957	0.000976	CcSEcCtD
Indapamide—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000955	0.000974	CcSEcCtD
Indapamide—Malaise—Methotrexate—ankylosing spondylitis	0.000948	0.000967	CcSEcCtD
Indapamide—Vertigo—Methotrexate—ankylosing spondylitis	0.000944	0.000963	CcSEcCtD
Indapamide—Leukopenia—Methotrexate—ankylosing spondylitis	0.000941	0.00096	CcSEcCtD
Indapamide—Urticaria—Betamethasone—ankylosing spondylitis	0.000936	0.000955	CcSEcCtD
Indapamide—Urticaria—Dexamethasone—ankylosing spondylitis	0.000936	0.000955	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000935	0.000954	CcSEcCtD
Indapamide—Dizziness—Prednisolone—ankylosing spondylitis	0.000934	0.000953	CcSEcCtD
Indapamide—Asthenia—Triamcinolone—ankylosing spondylitis	0.000932	0.00095	CcSEcCtD
Indapamide—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000932	0.00095	CcSEcCtD
Indapamide—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000932	0.00095	CcSEcCtD
Indapamide—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000932	0.00095	CcSEcCtD
Indapamide—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000932	0.00095	CcSEcCtD
Indapamide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00093	0.000948	CcSEcCtD
Indapamide—Insomnia—Prednisone—ankylosing spondylitis	0.000928	0.000947	CcSEcCtD
Indapamide—Paraesthesia—Prednisone—ankylosing spondylitis	0.000922	0.00094	CcSEcCtD
Indapamide—Pruritus—Triamcinolone—ankylosing spondylitis	0.000919	0.000937	CcSEcCtD
Indapamide—Cough—Methotrexate—ankylosing spondylitis	0.000917	0.000935	CcSEcCtD
Indapamide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000917	0.000935	CcSEcCtD
Indapamide—Dyspepsia—Prednisone—ankylosing spondylitis	0.000904	0.000921	CcSEcCtD
Indapamide—Myalgia—Methotrexate—ankylosing spondylitis	0.000895	0.000913	CcSEcCtD
Indapamide—Arthralgia—Methotrexate—ankylosing spondylitis	0.000895	0.000913	CcSEcCtD
Indapamide—Chest pain—Methotrexate—ankylosing spondylitis	0.000895	0.000913	CcSEcCtD
Indapamide—Decreased appetite—Prednisone—ankylosing spondylitis	0.000892	0.00091	CcSEcCtD
Indapamide—Rash—Prednisolone—ankylosing spondylitis	0.000891	0.000908	CcSEcCtD
Indapamide—Dermatitis—Prednisolone—ankylosing spondylitis	0.00089	0.000907	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000889	0.000906	CcSEcCtD
Indapamide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000887	0.000904	CcSEcCtD
Indapamide—Fatigue—Prednisone—ankylosing spondylitis	0.000885	0.000902	CcSEcCtD
Indapamide—Headache—Prednisolone—ankylosing spondylitis	0.000885	0.000902	CcSEcCtD
Indapamide—Discomfort—Methotrexate—ankylosing spondylitis	0.000884	0.000902	CcSEcCtD
Indapamide—Constipation—Prednisone—ankylosing spondylitis	0.000878	0.000895	CcSEcCtD
Indapamide—Dizziness—Triamcinolone—ankylosing spondylitis	0.000859	0.000876	CcSEcCtD
Indapamide—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000858	0.000875	CcSEcCtD
Indapamide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000857	0.000874	CcSEcCtD
Indapamide—Infection—Methotrexate—ankylosing spondylitis	0.000852	0.000869	CcSEcCtD
Indapamide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000846	0.000863	CcSEcCtD
Indapamide—Asthenia—Dexamethasone—ankylosing spondylitis	0.000846	0.000862	CcSEcCtD
Indapamide—Asthenia—Betamethasone—ankylosing spondylitis	0.000846	0.000862	CcSEcCtD
Indapamide—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000841	0.000858	CcSEcCtD
Indapamide—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00084	0.000857	CcSEcCtD
Indapamide—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000839	0.000856	CcSEcCtD
Indapamide—Nausea—Prednisolone—ankylosing spondylitis	0.000839	0.000856	CcSEcCtD
Indapamide—Pruritus—Dexamethasone—ankylosing spondylitis	0.000834	0.00085	CcSEcCtD
Indapamide—Pruritus—Betamethasone—ankylosing spondylitis	0.000834	0.00085	CcSEcCtD
Indapamide—Skin disorder—Methotrexate—ankylosing spondylitis	0.000833	0.00085	CcSEcCtD
Indapamide—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000829	0.000846	CcSEcCtD
Indapamide—Vomiting—Triamcinolone—ankylosing spondylitis	0.000826	0.000842	CcSEcCtD
Indapamide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000824	0.00084	CcSEcCtD
Indapamide—Rash—Triamcinolone—ankylosing spondylitis	0.000819	0.000835	CcSEcCtD
Indapamide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000818	0.000835	CcSEcCtD
Indapamide—Anorexia—Methotrexate—ankylosing spondylitis	0.000818	0.000834	CcSEcCtD
Indapamide—Rash—Methylprednisolone—ankylosing spondylitis	0.000817	0.000833	CcSEcCtD
Indapamide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000817	0.000833	CcSEcCtD
Indapamide—Urticaria—Prednisone—ankylosing spondylitis	0.000816	0.000832	CcSEcCtD
Indapamide—Headache—Triamcinolone—ankylosing spondylitis	0.000814	0.00083	CcSEcCtD
Indapamide—Headache—Methylprednisolone—ankylosing spondylitis	0.000812	0.000828	CcSEcCtD
Indapamide—Abdominal pain—Prednisone—ankylosing spondylitis	0.000812	0.000828	CcSEcCtD
Indapamide—Body temperature increased—Prednisone—ankylosing spondylitis	0.000812	0.000828	CcSEcCtD
Indapamide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000807	0.000822	CcSEcCtD
Indapamide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000807	0.000822	CcSEcCtD
Indapamide—Hypotension—Methotrexate—ankylosing spondylitis	0.000802	0.000817	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000782	0.000797	CcSEcCtD
Indapamide—Dizziness—Dexamethasone—ankylosing spondylitis	0.00078	0.000795	CcSEcCtD
Indapamide—Dizziness—Betamethasone—ankylosing spondylitis	0.00078	0.000795	CcSEcCtD
Indapamide—Insomnia—Methotrexate—ankylosing spondylitis	0.000776	0.000791	CcSEcCtD
Indapamide—Nausea—Triamcinolone—ankylosing spondylitis	0.000772	0.000787	CcSEcCtD
Indapamide—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00077	0.000786	CcSEcCtD
Indapamide—Nausea—Methylprednisolone—ankylosing spondylitis	0.00077	0.000785	CcSEcCtD
Indapamide—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000765	0.00078	CcSEcCtD
Indapamide—Somnolence—Methotrexate—ankylosing spondylitis	0.000763	0.000778	CcSEcCtD
Indapamide—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000756	0.000771	CcSEcCtD
Indapamide—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000755	0.00077	CcSEcCtD
Indapamide—Vomiting—Dexamethasone—ankylosing spondylitis	0.000749	0.000764	CcSEcCtD
Indapamide—Vomiting—Betamethasone—ankylosing spondylitis	0.000749	0.000764	CcSEcCtD
Indapamide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000746	0.00076	CcSEcCtD
Indapamide—Rash—Dexamethasone—ankylosing spondylitis	0.000743	0.000758	CcSEcCtD
Indapamide—Rash—Betamethasone—ankylosing spondylitis	0.000743	0.000758	CcSEcCtD
Indapamide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000743	0.000757	CcSEcCtD
Indapamide—Dermatitis—Betamethasone—ankylosing spondylitis	0.000743	0.000757	CcSEcCtD
Indapamide—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000741	0.000755	CcSEcCtD
Indapamide—Fatigue—Methotrexate—ankylosing spondylitis	0.00074	0.000754	CcSEcCtD
Indapamide—Headache—Dexamethasone—ankylosing spondylitis	0.000738	0.000753	CcSEcCtD
Indapamide—Headache—Betamethasone—ankylosing spondylitis	0.000738	0.000753	CcSEcCtD
Indapamide—Asthenia—Prednisone—ankylosing spondylitis	0.000737	0.000751	CcSEcCtD
Indapamide—Pain—Methotrexate—ankylosing spondylitis	0.000734	0.000748	CcSEcCtD
Indapamide—Pruritus—Prednisone—ankylosing spondylitis	0.000726	0.000741	CcSEcCtD
Indapamide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000707	0.000721	CcSEcCtD
Indapamide—Diarrhoea—Prednisone—ankylosing spondylitis	0.000702	0.000716	CcSEcCtD
Indapamide—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000702	0.000715	CcSEcCtD
Indapamide—Nausea—Dexamethasone—ankylosing spondylitis	0.0007	0.000714	CcSEcCtD
Indapamide—Nausea—Betamethasone—ankylosing spondylitis	0.0007	0.000714	CcSEcCtD
Indapamide—Urticaria—Methotrexate—ankylosing spondylitis	0.000682	0.000695	CcSEcCtD
Indapamide—Dizziness—Prednisone—ankylosing spondylitis	0.000679	0.000692	CcSEcCtD
Indapamide—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000678	0.000692	CcSEcCtD
Indapamide—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000678	0.000692	CcSEcCtD
Indapamide—Vomiting—Prednisone—ankylosing spondylitis	0.000653	0.000666	CcSEcCtD
Indapamide—Rash—Prednisone—ankylosing spondylitis	0.000647	0.00066	CcSEcCtD
Indapamide—Dermatitis—Prednisone—ankylosing spondylitis	0.000647	0.000659	CcSEcCtD
Indapamide—Headache—Prednisone—ankylosing spondylitis	0.000643	0.000656	CcSEcCtD
Indapamide—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000632	0.000645	CcSEcCtD
Indapamide—Asthenia—Methotrexate—ankylosing spondylitis	0.000616	0.000628	CcSEcCtD
Indapamide—Nausea—Prednisone—ankylosing spondylitis	0.00061	0.000622	CcSEcCtD
Indapamide—Pruritus—Methotrexate—ankylosing spondylitis	0.000607	0.000619	CcSEcCtD
Indapamide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000587	0.000599	CcSEcCtD
Indapamide—Dizziness—Methotrexate—ankylosing spondylitis	0.000567	0.000579	CcSEcCtD
Indapamide—Vomiting—Methotrexate—ankylosing spondylitis	0.000545	0.000556	CcSEcCtD
Indapamide—Rash—Methotrexate—ankylosing spondylitis	0.000541	0.000552	CcSEcCtD
Indapamide—Dermatitis—Methotrexate—ankylosing spondylitis	0.00054	0.000551	CcSEcCtD
Indapamide—Headache—Methotrexate—ankylosing spondylitis	0.000537	0.000548	CcSEcCtD
Indapamide—Nausea—Methotrexate—ankylosing spondylitis	0.00051	0.00052	CcSEcCtD
